(VIANEWS) – New York Community Bancorp (NYCB), Harmony Biosciences Holdings (HRMY), Chart Industries (GTLS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. New York Community Bancorp (NYCB)
48.6% sales growth and 8.19% return on equity
New York Community Bancorp, Inc. operates as a bank holding company for New York Community Bank that provides banking products and services in Metro New York, New Jersey, Ohio, Florida, and Arizona. The company offers various deposit products, including interest-bearing checking and money market, savings, non-interest-bearing, and individual retirement accounts, as well as certificates of deposit. It also provides multi-family loans; commercial real estate loans; specialty finance loans and leases, and other commercial and industrial loans; acquisition, development, and construction loans; one-to-four family loans; and consumer loans. In addition, the company offers annuities, life and long-term care insurance products, and mutual funds; cash management products; and online, mobile, and phone banking services. It primarily serves individuals, small and mid-size businesses, and professional associations through a network of 238 community bank branches and 348 ATM locations. The company was formerly known as Queens County Bancorp, Inc. and changed its name to New York Community Bancorp, Inc. in November 2000. New York Community Bancorp, Inc. was founded in 1859 and is headquartered in Westbury, New York.
Earnings Per Share
As for profitability, New York Community Bancorp has a trailing twelve months EPS of $1.26.
PE Ratio
New York Community Bancorp has a trailing twelve months price to earnings ratio of 7.25. Meaning, the purchaser of the share is investing $7.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.19%.
Moving Average
New York Community Bancorp’s value is below its 50-day moving average of $9.29 and below its 200-day moving average of $9.39.
2. Harmony Biosciences Holdings (HRMY)
34.3% sales growth and 61.58% return on equity
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $2.87.
PE Ratio
Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 15.07. Meaning, the purchaser of the share is investing $15.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 61.58%.
Volume
Today’s last reported volume for Harmony Biosciences Holdings is 555163 which is 0.11% above its average volume of 554551.
Yearly Top and Bottom Value
Harmony Biosciences Holdings’s stock is valued at $43.24 at 10:22 EST, way below its 52-week high of $62.08 and way above its 52-week low of $33.04.
3. Chart Industries (GTLS)
32.3% sales growth and 4.82% return on equity
Chart Industries, Inc. manufactures and sells engineered equipment for the energy and industrial gas industries worldwide. The company operates through four segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing. It provides bulk and packaged gas cryogenic solutions for the storage, distribution, vaporization, and application of industrial gases; cryogenic trailers, ISO containers, bulk storage tanks, loading facilities, and regasification equipment for delivering liquefied natural gas (LNG) into virtual pipeline applications; and large vacuum insulated storage tanks as equipment for purchasers of standard liquefaction plants. The company also offers process technology, liquefaction train, and critical equipment for the LNG, including small to mid-scale facilities, floating LNG applications, and large base-load export facilities; brazed aluminum, Core-in-Kettle, heat exchangers, cold boxes, air cooled heat exchangers, pressure vessels, and pipe works; and air cooled heat exchangers and axial cooling fans for the power, heating, ventilation, air conditioning, and refining applications. In addition, it provides highly engineered equipment that is used in specialty end-market applications for hydrogen, LNG, biogas, CO2 Capture, food and beverage, aerospace, lasers, cannabis, and water treatment; and cryogenic components, including vacuum insulated pipes, specialty liquid nitrogen, end-use equipment, and cryogenic flow meters. Additionally, it provides extended warranties, plant start-up, parts, 24/7 support, monitoring and process optimization, repairing, maintenance, and upgrading services; plant services on equipment, including brazed aluminum heat exchangers, cold boxes, etc.; and service locations that undertake installation, service, repair, maintenance, and refurbishment of cryogenic products, as well as equipment leasing solutions. The company was founded in 1859 and is based in Ball Ground, Georgia.
Earnings Per Share
As for profitability, Chart Industries has a trailing twelve months EPS of $8.65.
PE Ratio
Chart Industries has a trailing twelve months price to earnings ratio of 16.06. Meaning, the purchaser of the share is investing $16.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.82%.
Sales Growth
Chart Industries’s sales growth is 30.4% for the present quarter and 32.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 135.6% and 76.9%, respectively.
Moving Average
Chart Industries’s value is way higher than its 50-day moving average of $126.09 and way under its 200-day moving average of $164.77.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.5%, now sitting on 1.55B for the twelve trailing months.
4. Globus Medical (GMED)
6.6% sales growth and 10.6% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.77.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 30.8. Meaning, the purchaser of the share is investing $30.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 21.4% and 5.4%, respectively.
5. Camden Property Trust (CPT)
6% sales growth and 14.19% return on equity
Camden Property Trust, an S&P 400 Company, is a real estate company primarily engaged in the ownership, management, development, redevelopment, acquisition, and construction of multifamily apartment communities. Camden owns interests in and operates 167 properties containing 56,850 apartment homes across the United States. Upon completion of 7 properties currently under development, the Company's portfolio will increase to 59,104 apartment homes in 174 properties. Camden has been recognized as one of the 100 Best Companies to Work For® by FORTUNE magazine for 13 consecutive years, most recently ranking #18. The Company also received a Glassdoor Employees' Choice Award in 2020, ranking #25 for large U.S. companies.
Earnings Per Share
As for profitability, Camden Property Trust has a trailing twelve months EPS of $6.04.
PE Ratio
Camden Property Trust has a trailing twelve months price to earnings ratio of 18.34. Meaning, the purchaser of the share is investing $18.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.19%.
Volume
Today’s last reported volume for Camden Property Trust is 849752 which is 2.68% below its average volume of 873205.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21%, now sitting on 1.43B for the twelve trailing months.
Yearly Top and Bottom Value
Camden Property Trust’s stock is valued at $110.79 at 10:22 EST, way under its 52-week high of $175.69 and higher than its 52-week low of $107.90.
